BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
McKesson
Argus Health
Accenture
Moodys
US Department of Justice
Fish and Richardson
Cerilliant
Dow

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050575

« Back to Dashboard

NDA 050575 describes AUGMENTIN '250', which is a drug marketed by Dr Reddys Labs Inc and is included in three NDAs. It is available from five suppliers. Additional details are available on the AUGMENTIN '250' profile page.

The generic ingredient in AUGMENTIN '250' is amoxicillin; clavulanate potassium. There are forty-four drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Summary for 050575
Tradename:AUGMENTIN '250'
Applicant:Dr Reddys Labs Inc
Ingredient:amoxicillin; clavulanate potassium
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050575
Ingredient-typePenicillins
Mechanism of Actionbeta Lactamase Inhibitors
Suppliers and Packaging for NDA: 050575
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AUGMENTIN '125' amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 050575 NDA Rebel Distributors Corp 42254-282 42254-282-00 100 mL in 1 BOTTLE (42254-282-00)
AUGMENTIN '125' amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 050575 NDA Dr. Reddy's Laboratories Inc 43598-004 43598-004-53 150 mL in 1 BOTTLE (43598-004-53)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength125MG/5ML;EQ 31.25MG BASE/5ML
Approval Date:Aug 6, 1984TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength250MG/5ML;EQ 62.5MG BASE/5ML
Approval Date:Aug 6, 1984TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKesson
Harvard Business School
Chubb
US Department of Justice
Baxter
Fish and Richardson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot